Mivax Therapeutics, Inc.

Biotechnology company · San Francisco, California, United States

Mivax Therapeutics, Inc. is a biotechnology company headquartered in San Francisco, California, United States. Its earliest recorded incorporation is in 2024. It has reported private securities offerings to the US SEC, most recently $107,500 sold in a notice filed in 2026.

Profile compiled from public records. Is this your company? Request a correction or update

Mivax Therapeutics at a glance

Typebiotechnology company

HeadquartersSan Francisco, California, United States

Earliest incorporation on record2024

SEC CIK2066303

What does Mivax Therapeutics do?

Private fundraising reported to the SEC

4 Form D notices; the most recent reported $107,500 sold (2026).

Frequently asked questions about Mivax Therapeutics

Where is Mivax Therapeutics headquartered?

Mivax Therapeutics, Inc. is headquartered in San Francisco, California, United States.

What does Mivax Therapeutics do?

Mivax Therapeutics, Inc. is a biotechnology company.

When was Mivax Therapeutics founded?

The earliest incorporation on record for Mivax Therapeutics, Inc. is in 2024, according to public company registers.

Similar companies

Ossium Health, Inc.San Francisco, California, United States
Vir Biotechnology, Inc.San Francisco, California, United States
Titan Pharmaceuticals IncSan Francisco, California, United States
Senti Biosciences, Inc.San Francisco, California, United States
Amygdala Neurosciences IncSan Francisco, California, United States
Excision BioTherapeutics IncSan Francisco, California, United States
ProLynx, Inc.San Francisco, California, United States
Second Genome, Inc.San Francisco, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences